CIK 0001527728 · Non-accelerated filer<br>Smaller reporting company
Lunai Bioworks Inc.
Sign in to watch- Ticker
- LNAI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 452259340
- Phone
- 45 39179840
- Business address
- CENTURY CITY MEDICAL PLAZA, 2080 CENTURY CITY EAST, SUITE 906 LOS ANGELES, CA, 90067
- Former names
- RENOVARO INC., RENOVARO BIOSCIENCES INC., Enochian Biosciences Inc, DanDrit Biotech USA, Inc., Putnam Hills Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-08-01 | Sindlev Rene Director | Grant or award · Series A Convertible Preferred Stock | +70,126 | $7.13 | $500K | 70,126 |
| 2023-08-01 | Sindlev Rene Director | Grant or award · Warrant (Right to Buy) | +350,630 | 350,630 | ||
| 2023-07-30 | Sindlev Rene Director | Grant or award · Option to purchase shares of Common Stock | +131,579 | 131,579 | ||
| 2023-06-26 | Sindlev Rene Director | Grant or award | +1,886,794 | $0.53 | $1.0M | 12,432,338 |
| 2023-06-26 | Sindlev Rene Director | Grant or award · Warrant (Right to Buy) | +943,397 | 943,397 | ||
| 2023-05-26 | McNicol Jayne Director | Grant or award · Option to Purchase Common Stock | +79,787 | 79,787 | ||
| 2023-03-17 | Sindlev Rene Director | Grant or award | +877,193 | $1.14 | $1.0M | 10,545,544 |
| 2023-03-17 | Sindlev Rene Director | Grant or award · Warrant (Right to Buy) | +438,597 | 438,597 | ||
| 2023-03-06 | SAPIRSTEIN JAMES Director | Grant or award · Option to Purchase Common Stock | +64,655 | 64,655 | ||
| 2022-12-27 | Alton Gregg H Director | Grant or award · Option to purchase shares of common stock | +57,252 | 57,252 | ||
| 2022-12-27 | Brosgart Carol L Director | Grant or award · Option to purchase shares of common stock | +57,252 | 57,252 | ||
| 2022-10-18 | Binette Francois Executive VP for R&D | Grant or award · Option to purchase shares of common stock | +40,000 | 40,000 | ||
| 2022-10-18 | Puche Luisa Chief Financial Officer | Grant or award · Option to purchase shares of common stock | +80,000 | 80,000 | ||
| 2022-10-13 | William Anderson Wittekind 10% owner | Other acquisition | +1,216,467 | 1,313,499 | ||
| 2022-10-13 | Weird Science LLC 10% owner | Other acquisition | +1,216,467 | 1,313,499 | ||
| 2022-10-09 | Gronfeldt-Sorensen Henrik Director | Grant or award · Option to purchase shares of common stock | +45,455 | 45,455 | ||
| 2022-08-25 | Dybul Mark Chief Executive Officer | Grant or award · Option to purchase shares of common stock | +350,000 | 350,000 | ||
| 2022-07-30 | Sindlev Rene Director | Grant or award · Option to Purchase Shares of Common Stock | +32,609 | 32,609 | ||
| 2022-07-20 | Puche Luisa Chief Financial Officer | Grant or award · Option to purchase shares of common stock | +75,000 | 75,000 | ||
| 2022-06-08 | Sindlev Rene Director | Other disposition | −125,000 | 0 |
Page 5 of 10 · 198 trades